摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-N-(4-ethoxyphenyl)pyridine-2,3,5-triamine | 1421589-74-3

中文名称
——
中文别名
——
英文名称
2-N-(4-ethoxyphenyl)pyridine-2,3,5-triamine
英文别名
——
2-N-(4-ethoxyphenyl)pyridine-2,3,5-triamine化学式
CAS
1421589-74-3
化学式
C13H16N4O
mdl
——
分子量
244.296
InChiKey
PDJNDWZXZSAROH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    86.2
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-N-(4-ethoxyphenyl)pyridine-2,3,5-triamine甲醇 为溶剂, 反应 6.0h, 生成
    参考文献:
    名称:
    Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles
    摘要:
    A series of potent arenavirus inhibitors sharing a benzimidazole core were previously reported by our group. SAR studies were expanded beyond the previous analysis, which involved the attached phenyl rings and methylamino linker portion, to include modifications focused on the benzimidazole core. These changes included the introduction of various substituents to the bicyclic benzimidazole ring system along with alternate core heterocycles. Many of the analogs containing alternate nitrogen-based bicyclic ring systems were found to retain antiviral potency compared to the benzimidazole series from which we derived our lead compound, ST-193. In fact, 21h, built on an imidazopyridine core, possessed a near tenfold increase in potency against Lassa virus pseudotypes compared to ST-193. As found with the benzimidazole series, broad-spectrum arenavirus activity was also observed for a number of the analogs discovered during this study. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.11.093
  • 作为产物:
    描述:
    2-氟-3,5-二硝基吡啶 在 palladium 10% on activated carbon 、 氢气caesium carbonate 作用下, 以 四氢呋喃乙酸乙酯 为溶剂, 生成 2-N-(4-ethoxyphenyl)pyridine-2,3,5-triamine
    参考文献:
    名称:
    Antiviral drugs for treatment of Arenavirus infection
    摘要:
    本发明涉及用于治疗病毒感染的化合物、方法和药物组合物,通过在治疗上有效剂量下给予某些化合物来进行治疗。还公开了制备这些化合物的方法以及使用这些化合物和药物组合物的方法。特别是针对由Arenavirus家族引起的病毒感染的治疗和预防,如拉萨热、阿根廷出血热、玻利维亚出血热和委内瑞拉出血热。
    公开号:
    US09096597B2
点击查看最新优质反应信息

文献信息

  • Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles
    作者:James R. Burgeson、Amy L. Moore、Dima N. Gharaibeh、Ryan A. Larson、Natasha R. Cerruti、Sean M. Amberg、Dennis E. Hruby、Dongcheng Dai
    DOI:10.1016/j.bmcl.2012.11.093
    日期:2013.2
    A series of potent arenavirus inhibitors sharing a benzimidazole core were previously reported by our group. SAR studies were expanded beyond the previous analysis, which involved the attached phenyl rings and methylamino linker portion, to include modifications focused on the benzimidazole core. These changes included the introduction of various substituents to the bicyclic benzimidazole ring system along with alternate core heterocycles. Many of the analogs containing alternate nitrogen-based bicyclic ring systems were found to retain antiviral potency compared to the benzimidazole series from which we derived our lead compound, ST-193. In fact, 21h, built on an imidazopyridine core, possessed a near tenfold increase in potency against Lassa virus pseudotypes compared to ST-193. As found with the benzimidazole series, broad-spectrum arenavirus activity was also observed for a number of the analogs discovered during this study. (c) 2012 Elsevier Ltd. All rights reserved.
  • Antiviral drugs for treatment of Arenavirus infection
    申请人:Kineta Four, LLC
    公开号:US09096597B2
    公开(公告)日:2015-08-04
    Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever.
    本发明涉及用于治疗病毒感染的化合物、方法和药物组合物,通过在治疗上有效剂量下给予某些化合物来进行治疗。还公开了制备这些化合物的方法以及使用这些化合物和药物组合物的方法。特别是针对由Arenavirus家族引起的病毒感染的治疗和预防,如拉萨热、阿根廷出血热、玻利维亚出血热和委内瑞拉出血热。
查看更多